The Plasma Therapy called convalescent plasma treatment, requires blood plasma donations from people who have recovered from Covid-19. This plasma is administered to Covid-19 patients who could not generate sufficient antibodies against the virus.
According to scientists,”Convalescent plasma is a promising treatment that could help patients whose bodies aren’t producing enough antibodies to curb the disease. This trial will help us understand whether the treatment should be used more widely to treat Covid-19.”
Last month, the UK Government approved a national clinical trial to assess plasma therapy for the treatment of Covid-19 patients. The trial will assess the effectiveness of convalescent plasma, which is obtained from recovered patients, in severely ill Covid-19 patients. A scaled-up national programme, if effective, will supply up to 10,000 units of convalescent plasma each week to the NHS, enabling the treatment of 5,000 patients per week.
In India, this extraordinary and costly treatment is still under trial. In a country like India where the population is more than double in comparison to any other country it’s difficult to provide this treatment to each Covid-19 survivor.